NCT00003890View on ClinicalTrials.gov

MG98 in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

February 22, 1999

Primary Completion Date

September 27, 2001

Study Completion Date

September 22, 2008

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

MG 98

Trial Locations (2)

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

K1H 1C4

Ottawa Regional Cancer Centre, Ottawa

Sponsors
All Listed Sponsors
lead

NCIC Clinical Trials Group

NETWORK